Small U.S. Stocks Finish Mixed As Bausch Health Lead, LiveWire Group Lags
Bausch & Lomb May Be Worth About $28 a Share in Takeover - Analyst
Private equity is interested in acquiring Bausch + Lomb (BLCO.US), which has surged more than 5%.
According to foreign media reports, private equity firm intends to acquire Bausch & Lomb (BLCO.US), the stock rose 8.51% at the time of writing.
Eye Health Supplements Global Outlook & Forecasts 2024-2029 With Amway, Bausch Health Companies, Nature's Bounty, Vitabiotics, and ZeaVision Leading the $3.28 Billion Market - ResearchAndMarkets.com
Jefferies Maintains Bausch Health(BHC.US) With Buy Rating, Cuts Target Price to $9
Jefferies analyst Glen Santangelo maintains $Bausch Health(BHC.US)$ with a buy rating, and adjusts the target price from $13 to $9.According to TipRanks data, the analyst has a success rate of 54.5%
Bausch + Lomb Shares Up in Premarket Amid Sale Consideration